News & Events
After a short administrative update, each meeting will include two Project updates (~ 45 mins / project) or 3 Core updates (25 mins / core). Each presentation is coordinated by the designated Project, Core, or CDP lead. The lead will consult with the PIs on their project/core and designate who will present and how the presentations will be constituted, preferably including a mix of senior and junior level presenters each month.
Teleconference meetings are held the 3rd Friday of each month at 10:00-11:30 AM PT.
2025
January 17 – Invited Speaker: Janet Iwasa, PhD. “Molecular Visualization, Scientific Outreach & Education.”
February 13-14 – Winter F2F Meeting
March 21 – Invited Speaker: Nathan Sherer, PhD. “Why does HIV-1 modulate the cell cycle?”
April 18 – Cores 1 & 2 updates
May 16 – Cores 3 & 4 updates
June 23-25 – TBD
July 18 – Invited Speaker
August 15 – Project 1 updates
September 19 – Project 2 updates
October 17 – Updates from CDAs
November 21 – Project 3 updates
December 19 – No meeting, Happy Holidays!
B-HIVE Winter Face-to-Face Meeting
The 4th annual B-HIVE Winter F2F meeting will be February 5-6, 2026, at the Emory Conference Center.
Address: 1615 Clifton Rd, Atlanta, GA 30329 Phone: 404-712-6000
We will hold an in-person Training Workshop and a Welcome Reception on the day before the meeting, Wednesday, February 4, 2026.
More details coming soon!
B-HIVE Winter Face-to-Face Meeting
The 3rd annual B-HIVE Winter F2F meeting was held on February 13-14, 2025 at the Emory Conference Center (Address: 1615 Clifton Rd, Atlanta, GA 30329; Phone: 404-712-6000; https://www.emoryconferencecenter.com).
We held an in-person training workshop based on mass spec-related methods on the day before the main meeting.
We began with a welcome reception at Wisteria Lanes on Wednesday evening (7 – 10 pm), project and core presentations started Thursday morning, a Thursday poster session, and a breakout session and recap on Friday. Breakfast, lunch, coffee breaks and snacks were provided on Thursday and Friday, and dinner was provided on Thursday night. The meeting ended at 4 pm on Friday.
Day One Presentations:
- Project 1 – Mamuka Kavaratskhelia and Stefan Sarafianos
- Project 2 – Alan Engelman and Vinay Pathak
- Project 3 – Wei-Shau Hu and Bruce Torbett
- Core 1 – Greg Voth and Stefano Forli
- Core 2 – Dmitry Lyumkis and Rob Dick
- Core 3 – Greg Melikian, David Millar, and Karin Musier-Forsyth
Day Two Presentations:
- Core 4 – Mary Kearney and Andrew Routh
- Core 5 – Karen Kirby and Christian Gallardo
- CDP Awardees – Megan Ken, Ludovic Autin, and Guochun Jiang
B-HIVE Winter Training Retreat
February 12, 2025
On Wednesday, February 12, 2025, we held an in-person training workshop led by Drs. Kaylee Grabarkewitz, Patrick Griffin, Timothy O’Leary, and Vicki Wysocki, based on mass spec-related methods. The workshop began at 1pm, on the day prior to the B-HIVE Face-to-Face meeting. A video recording of this workshop will be available by the end of March 2025.
Pat Griffin and Tim O’Leary presented, “HDX-MS for analysis of non-covalent protein-ligand interactions, and proteomics for analysis of covalent ligands.”
Vicki Wysocki and Kaylee Grabarkewitz presented, “Complementarity of Native MS with cryoEM and Mass Photometry.”
Dr. Art Olson provided an informal workshop and demonstration using VR technology, “Exploring and Learning about Virus Structure and Symmetry in an Augmented Reality environment.”
A short movie of this demo is available here: https://drive.google.com/file/d/1WSVNfyQwdo3C–w8Bq6zWIgCXcjUv-RV/view?usp=sharing
The National Institute for Allergy and Infectious Diseases (NIAID) will host the annual HIV Structural Biology Meeting Monday, June 23rd and Tuesday, June 24th, 2025 virtually. Invites will be sent from NIAID to B-HIVE Center members only. Each Center will present research updates for 1 hour, as in past meetings.
The 2025 Summer Face-to-Face meeting has been rescheduled to the Fall. This year it will be held on Monday, October 6, 2025, as a virtual-only, half-day meeting. Agenda to follow soon!
The Latest Buzz
Congratulations to David Goodsell, PhD! His illustration of HIV budding is published on the cover of American Scientist Magazine.
Please join us in celebrating the publishing of David’s beautiful artwork in the September-October 2025 issue of American Scientist.
September-October – 2025 – Volume: 113 – Number: 5 | American Scientist
Congratulations to Janet Iwasa, PhD, recipient of the 2025 ASCB Bruce Alberts Award for Excellence in Science Education
B-HIVE Center member Janet Iwasa was recently awarded the 2025 Bruce Alberts Award for Excellence in Science Education from the American Society for Cell Biology (ASCB)! This award is given to an individual who has demonstrated innovative and sustained contributions to science education, prioritizing the national impact of the nominee’s activities.
Congratulations, Janet!
Congratulations to Greg Voth, PhD, recipient of the 2025 ACS Award in Theoretical Chemistry
Please join us in congratulating Greg on this prestigious award!
We are delighted to share that Greg Voth, PhD, a Haig P. Papazian Distinguished Service Professor (Voth Group), Department of Chemistry, University of Chicago, has been awarded the American Chemical Society National Theoretical Chemistry Award for his groundbreaking work in field of computational chemistry.
Congratulations to this year’s CDP Awardee
We are pleased to announce that Charles Bou-Nader, PhD, an Assistant Professor (Bou-Nader Lab), Department of Biochemistry, at Emory University, is our CDP recipient for 2025-2026. Information on his proposed studies is below.
Molecular basis of HIV-1 integration at R-loop structures
The proposed work will define the fundamental principles of how HIV selects its integration sites on the genome to sustain a long-term infection. The overarching hypothesis is that non-B form DNA structures induced by nuclear RNAs are preferentially recognized by the intasome for integration. By combining biochemical, structural and biophysical approaches we will uncover new rules of integration paving the way for new antiretrovirals.